The proposed bill establishes the Task Force on Diabetes Management within the Department of Health, which will assess the need for a referral program for individuals diagnosed with diabetes to federally qualified health centers, irrespective of their health coverage status. The task force is tasked with developing referral criteria and must submit a report to the Governor and Legislature by May 1, 2026. Additionally, the bill allows the State Surgeon General to reestablish the task force if necessary and mandates the creation of a program by January 1, 2027, unless certain conditions are met. The Department of Health is also required to create a website to facilitate information sharing and appointment scheduling for referred individuals.

Moreover, the bill enhances coverage for diabetes-related drugs and devices under health insurance policies in Florida by introducing definitions for various diabetes management tools and mandating coverage for laboratory and diagnostic testing without certain cost-sharing requirements. It caps out-of-pocket expenses at $35 for a 30-day supply of insulin, noninsulin, or glucagon drugs, and $100 for a 30-day supply of all medically necessary diabetes and diabetic ketoacidosis devices. The bill also requires health maintenance contracts to provide similar coverage and cost-sharing limits and amends the prescription drug monitoring program to include reporting requirements for diabetes-related items. The act is set to take effect on July 1, 2025, and applies to all health insurance policies and contracts delivered, issued, renewed, or amended on or after January 1, 2026.